While the antiparasitic drug ivermectin is being touted as a treatment for COVID-19 in many parts of the world, Taiwanese experts on Monday warned against regular use of the drug in COVID-19 treatment, citing a lack of solid evidence.
“Following an experts’ meeting, we do not recommend regular use of ivermectin in treating COVID-19 due to the lack of enough evidence,” said Chang Shan-chwen (張上淳), convener of the Central Epidemic Command Center’s (CECC) expert advisory panel.
A report in the American Journal of Therapeutics said that meta-analyses based on 18 randomized controlled treatment trials of ivermectin in COVID-19 patients had found large, statistically significant reductions in mortality, time to clinical recovery and time to viral clearance.
“Furthermore, results from numerous controlled prophylaxis trials report significantly reduced risks of contracting COVID-19 with the regular use of ivermectin,” the report said.
Although initial findings showed that ivermectin seemed effective in the prevention and treatment of COVID-19, Chang said that no meaningful evidence has been provided to verify that it helps bring down patients’ mortality or intubation rate.
Neither is there evidence to prove that it speeds up the elimination of the coronavirus or shortens the length of a patient’s hospital stay, because of the limited number of cases studied, he said.
Ivermectin, a medication used to treat many types of parasitic infestations, was first used in 1988 to treat river blindness, a disease caused by infection from the parasitic worm Onchocerca volvulus.
Since 2012, several studies have shown the antiviral effects of ivermectin on viruses such as influenza, dengue fever and AIDS.
As neither the WHO, the EU or the US have included ivermectin use in their guidelines for COVID-19 treatment, the center decided not to recommend regular use of the drug for such a purpose, Chang said.
He warned COVID-19 patients against buying the drug over the counter to treat the disease due to potential side effects caused by inappropriate use.
FUKUOKA SITUATION: Japanese media reported that the pathogen is expected to be identified by the summer, while the CDC downplayed the idea that it was hMPV A “mysterious cold-like illness” reported in Japan’s Fukuoka Prefecture does not seem to be a new disease, but Japanese authorities have been asked about the situation, the Centers for Disease Control (CDC) said yesterday. The Fukuoka Prefectural Medical Association on Wednesday told a news conference that a “mystery cold” that has become a hot topic on social media is “highly likely to be caused by some kind of viral infection,” Japan’s KBC News reported. “Many people are experiencing symptoms starting with a sore throat, followed by a runny nose, phlegm and a severe cough,” KBC News reported, citing association officials. Health authorities are
Nvidia Corp CEO Jensen Huang (黃仁勳) arrived in Taiwan yesterday ahead of upcoming AI and technology events, saying he plans to meet with clients and Taiwan Semiconductor Manufacturing Co Chairman C.C. Wei (魏哲家) during his visit. After landing at Taipei Songshan Airport, Huang posed for photos with fans and handed out Yakult drinks to reporters and supporters waiting at the scene, saying he has “a lot to do” during the trip. Asked about reports that Nvidia’s planned headquarters site in Taipei’s Beitou Shilin Technology Park could break ground on May 27, Huang said that if the company holds an event, he would
Carrefour Taiwan is to begin using a new name from the start of July, but it cannot divulge the name until then, the chairman of the supermarket chain's parent company said today. President Chain Store Co chairman Lo Chih-hsien (羅智先) was asked by reporters after a shareholders' meeting to confirm whether the company has settled on a new name for the supermarket brand. In March, the government-registered name of two Carrefour Taiwan branches was quietly changed to "Le Chia Kang" (樂家康) in Chinese, raising speculation that has been selected as the name. Lo said that because of local regulations and contractual obligations, the
The Philippines would likely be involved in any conflict over Taiwan due to its proximity to the democracy claimed by China, President Ferdinand Marcos Jr said, reiterating a stance that risks angering Beijing. “In the Philippines, we do not have a choice because Taiwan is so close to the Philippines and we have almost 200,000 Filipino nationals living and working in Taiwan,” Marcos said in an interview with Japanese media in Manila on Monday. The Philippine leader’s comments come ahead of a state visit to Japan next week, where he is to meet with Japanese Prime Minister Sanae Takaichi to discuss security
RSS